Researchers to compare three most common treatments for sleep apnea for effectiveness
By HME News Staff
Updated 10:19 AM CDT, Tue May 12, 2026
TUCSON, Az. – University of Arizona researchers will use a five-year, nearly $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to support a clinical trial comparing three common treatments for obstructive sleep apnea (OSA) for effectiveness. The three treatments: CPAP therapy, dental devices and oral medication. "Sleep apnea can significantly affect quality of life and is costly to the workforce through lost productivity," said Dr. Sairam Parthasarathy, director of the Center for Sleep, Circadian & Neuroscience Research and professor of medicine in the College of Medicine – Tucson. "Each of the three available therapies has benefits and downsides. Our goal is to understand which treatment works best for an individual patient." Parthasarathy and his team have previously received PCORI funding to study CPAP adherence and other strategies to improve sleep apnea treatment. PCORI is a nonprofit organization with a mission to fund patient-centered comparative clinical effectiveness research designed to provide patients and those who care for them with evidence to make better-informed health care decisions. For more information, visit the University of Arizona’s website.
Comments